Joseph Lipscomb - Concepedia

Author

Joseph Lipscomb

Also Known As

Barnett, Paul G., J Lipscomb, J. Lipscomb, J. M. Lipscomb, J.M. Lipscomb, JOSEPH LIPSCOMB, Jane Lipscomb, Joseph Lipscomb, Marino, Susana, Reeve, Bryce B.

236

Publications

7.8K

Citations

H-Index

155

Concepts

All Affiliations

Emory University Duke Medical Center Duke University National Cancer Institute Centers for Disease Control and Prevention

About

Joseph Lipscomb is an author at Emory University specializing in medicine, outcomes research, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Business	4	4	125
2	Health Sciences	4	4	250
3	Education	1	1	138
4	Engineering	1	1	19
5	Law	1	1	18

Joseph Lipscomb

Publications

5.2K

Citations

H-Index

Page 1

	Year	Citations
Understanding Cancer Treatment and Outcomes: The Cancer Care Outcomes Research and Surveillance Consortium John Z. Ayanian, Elizabeth A. Chrischilles, Robert B. Wallace, Journal of Clinical Oncology Cancer ManagementEpidemiology Of CancerCancer RegistrationSurveillance ConsortiumCancer Education	2004	252
Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer Onkar V. Khullar, Yuan Liu, Theresa Gillespie, Journal of Thoracic Oncology Surgical OncologyInterventional PulmonologyMedicineBronchial NeoplasmThoracic Surgery	2015	229
Patient-Reported Outcomes: Conceptual Issues Margaret Rothman, Philippe Beltran, Joseph C. Cappelleri, Value in Health NursingPatient-reported OutcomesPatient SafetyOutcomes ResearchPatient-reported Outcome	2007	218
Influence of Race, Insurance, Socioeconomic Status, and Hospital Type on Receipt of Guideline-Concordant Adjuvant Systemic Therapy for Locoregional Breast Cancers Xiao‐Cheng Wu, Mary Jo Lund, Gretchen Kimmick, Journal of Clinical Oncology	2011	192
Epidemiology of Recurrent Cerebral Infarction Gregory P. Samsa, John Bian, Joseph Lipscomb, Stroke	1999	191
First- and Second-Line Bevacizumab in Addition to Chemotherapy for Metastatic Colorectal Cancer: A United States–Based Cost-Effectiveness Analysis Daniel A. Goldstein, Qiushi Chen, Turgay Ayer, Journal of Clinical Oncology	2015	160
US Valuation of Health Outcomes Measured Using the PROMIS-29 Benjamin M. Craig, Bryce B. Reeve, Paul Brown, Value in Health Health EconomicsHealth OutcomeOutcomes ResearchUs ValuationPublic Health	2014	155
Racial differences in the presentation and outcomes of diffuse large B‐cell lymphoma in the United States Pareen J. Shenoy, Neha Malik, Ajay K. Nooka, Cancer	2010	153
Inpatient costs of specific cerebrovascular events at five academic medical centers. R G Holloway, D M Witter, Kirke B. Lawton, PubMed Cerebrovascular DiseaseHospital CostsVascular SurgeryNeurologyInpatient Costs	1996	152
Utilities for major stroke: Results from a survey of preferences among persons at increased risk for stroke Gregory P. Samsa, David B. Matchar, Larry B. Goldstein, American Heart Journal Stroke RehabilitationCardiovascular DiseaseIschemic StrokeHealth EconomicsMajor Stroke	1998	144

Page 1